HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuhiko Uoshima Selected Research

isatuximab

5/2024The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuhiko Uoshima Research Topics

Disease

20Multiple Myeloma
05/2024 - 11/2010
9Neoplasms (Cancer)
01/2023 - 04/2006
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 07/2003
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 04/2007
6Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 07/2003
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2024 - 01/2018
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 01/2002
4Philadelphia Chromosome
11/2023 - 04/2009
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 09/2010
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 04/2009
3Aplastic Anemia (Anemia, Hypoplastic)
12/2023 - 03/2019
3Leukemia
10/2015 - 06/2011
2Thrombocytopenia (Thrombopenia)
02/2024 - 01/2002
2COVID-19
12/2023 - 01/2023
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 04/2009
2Disseminated Intravascular Coagulation
01/2019 - 01/2012
2Encephalitis (Encephalitis, Rasmussen)
01/2018 - 09/2013
2Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 05/2017
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2017 - 05/2017
2Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 01/2012
2Lymphoma (Lymphomas)
09/2010 - 01/2007
1Cytopenia
02/2024
1Residual Neoplasm
11/2023
1Anemia
09/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1Extranodal NK-T-Cell Lymphoma
10/2022
1Frailty
03/2022
1Hypertension (High Blood Pressure)
01/2022
1Myeloid Sarcoma (Chloroma)
01/2021
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019
1Polycythemia (Erythrocytosis)
12/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2016
1Stevens-Johnson Syndrome (Lyell's Syndrome)
03/2016
1Disease Progression
12/2015
1Large Granular Lymphocytic Leukemia
10/2015
1Lymphocytosis
10/2015
1Hyponatremia
06/2015
1Critical Illness (Critically Ill)
06/2015
1Central Pontine Myelinolysis
06/2015
1Pathologic Complete Response
06/2015
1Thrombotic Thrombocytopenic Purpura
01/2013

Drug/Important Bio-Agent (IBA)

10Rituximab (Mabthera)FDA Link
01/2023 - 04/2007
9Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 11/2010
7Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2015
5Bortezomib (Velcade)FDA Link
01/2022 - 11/2010
5Dasatinib (BMS 354825)FDA Link
01/2018 - 04/2009
4carfilzomibIBA
03/2022 - 01/2022
4Bendamustine HydrochlorideFDA Link
01/2022 - 09/2010
3Azacitidine (5 Azacytidine)FDA Link
02/2024 - 01/2021
3Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 04/2014
3Prednisolone (Predate)FDA LinkGeneric
01/2020 - 04/2014
3Imatinib Mesylate (Gleevec)FDA Link
10/2015 - 04/2009
2pomalidomideIBA
05/2024 - 05/2018
2daratumumabIBA
03/2024 - 01/2022
2elotuzumabIBA
03/2024 - 01/2023
2romiplostimFDA Link
12/2023 - 01/2021
2Monoclonal AntibodiesIBA
01/2023 - 04/2007
2CCAAT-Enhancer-Binding Protein-alphaIBA
11/2022 - 01/2016
2Phosphotransferases (Kinase)IBA
11/2019 - 10/2018
2ThrombomodulinIBA
01/2019 - 01/2012
2NucleophosminIBA
10/2018 - 01/2016
2Tacrolimus (Prograf)FDA LinkGeneric
12/2004 - 07/2003
1isatuximabIBA
05/2024
1Bispecific AntibodiesIBA
03/2024
1Chimeric Antigen ReceptorsIBA
03/2024
1VaccinesIBA
12/2023
1Messenger RNA (mRNA)IBA
12/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1Serum AlbuminIBA
09/2023
1CholesterolIBA
09/2023
1obinutuzumabIBA
01/2023
1Neutralizing AntibodiesIBA
01/2023
1AnthracyclinesIBA
10/2022
1Proteasome InhibitorsIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1IntegrinsIBA
07/2021
1ixazomibIBA
04/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2019
1thymoglobulinFDA Link
03/2019
1defibrotideIBA
01/2019
1FoscarnetFDA LinkGeneric
01/2018
1Core Binding Factors (Core-Binding Factor)IBA
10/2017
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
12/2016
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
12/2016
1mogamulizumabIBA
03/2016
1Thalidomide (Thalomid)FDA Link
01/2016
1Tyrosine Kinase InhibitorsIBA
10/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015
1MethylprednisoloneFDA LinkGeneric
06/2015
1Vindesine (Vindesin)IBA
06/2015
1pirarubicinIBA
06/2015
1ElectrolytesIBA
06/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2013
1Galectin 3 (LGALS3)IBA
10/2011

Therapy/Procedure

26Therapeutics
03/2024 - 01/2007
11Drug Therapy (Chemotherapy)
11/2021 - 04/2006
7Stem Cell Transplantation
11/2021 - 07/2003
3Hematopoietic Stem Cell Transplantation
08/2022 - 01/2019
3Cell Transplantation
01/2016 - 03/2011
2Transplantation
02/2024 - 01/2018